Invention Publication
- Patent Title: METHOD AND SYSTEM FOR GENE EXPRESSION PREDICTION-BASED SCREENING OF DRUG-LIKE MOLECULES
-
Application No.: US18490025Application Date: 2023-10-19
-
Publication No.: US20240170108A1Publication Date: 2024-05-23
- Inventor: Broto CHAKRABARTY , Siladitya PADHI , Riya Dilipbhai SADRANI , Rajgopal SRINIVASAN , Arijit ROY
- Applicant: Tata Consultancy Services Limited
- Applicant Address: IN Mumbai
- Assignee: Tata Consultancy Services Limited
- Current Assignee: Tata Consultancy Services Limited
- Current Assignee Address: IN Mumbai
- Priority: IN 2221066851 2022.11.21
- Main IPC: G16C20/50
- IPC: G16C20/50 ; G16B20/00 ; G16B40/20 ; G16C20/70 ; G16H70/40

Abstract:
Traditional drug discovery methods are target-based, time- and resource-intensive, and require a lot of resources for the initial hit molecule identification. Phenotype-based drug screening requires differential gene expression data of a large number of molecules for different combinations of cell-line, time point and dosage. Experimentally obtaining gene expression data for all these combinations is again a heavily resource-intensive process. The technical challenge in conventional methods that use prediction models is that they depend largely on the data processing and representation. The disclosure herein generally relates to drug-like molecule screening, and, more particularly, to a method and system for gene expression and machine learning-based drug screening. The embodiment, thus, provides a mechanism of a small molecule-induced gene expression prediction based on machine learning models. Moreover, the embodiments herein further provide a mechanism of screening of drug-like molecules using the machine learning model(s).
Information query